Molecular characterization of the melanin-concentrating hormone/receptor complex: Identification of critical residues involved in binding and activation

Molecular Pharmacology

Volumn 58, Issue 1, 2000, Pages 217-225

  Macdonald, Douglas ^a   Murgolo, Nicholas ^a   Zhang, Rumin ^a   Durkin, James P ^a   Xiaorui, Yao ^a   Strader, Catherine D ^a   Graziano, Michael P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE RECEPTOR; MELANIN;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CHO CELL; COMPLEX FORMATION; DRUG EFFECT; LIGAND BINDING; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RESIDUE ANALYSIS; SITE DIRECTED MUTAGENESIS; STEREOCHEMISTRY;

EID: 0033938778     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.1.217     Document Type: Article

References (39)

1. Bachner D, Kreienkamp H, Weise C, Buck F and Richter D (1999) Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan Bomatostatin-like receptor 1 (SLC-1). FEBS Lett 457:522-524.
2. Ballesteros JA and Weinstein H (1995) Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G-protein coupled receptors. Methods Neurosci 25:366-428.
3. Befort K, Zilliox C, Filliol D, Yue S and Kieffer BL (1999) Constitutive activation of the delta opioid receptor by mutations in transmembrane domains III and VII. J Biol Chem 274:18574-18581.
4. Chambers J, Ames RS, Bergsma D, Muir A, Fitzgerald LR, Hervieu G, Dytko GM, Foley JJ, Martin J, Liu W-S, Park J, Ellis C, Ganguly S, Konchar S, Chuderay J, Leslie R, Wilson S and Sarau HM (1999) Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature (Lond) 400:261-265.
5. Fraser CM, Wang CD, Robinson DA, Gocayne JD and Venter JC (1989) Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: Conserved aspartic acids play important roles in receptor function. Mol Pharmacol 36:840-847.
6. Gantz I, DelValle J, Wang LD, Tashiro Wang, Munzert G, Guo YJ, Konda Y and Yamada T (1992) Molecular basis for the interaction of histaimne with the histamine H2 receptor. J Biol Chem 267:20840-20843.
7. Henderson R, Baldwin J, Ceska T, Zemlin F, Beckmann E and Downing K (1990) Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J Mol Biol 213:899-929.
8. Ho BY, Karschin A, Branchek T, Davidson N and Lester HA (1992) The role of conserved aspartate and serine residues in ligand binding and in function of the 5-HT1A receptor: A site-directed mutation study. FEBS Lett 312:259-262.
9. Javitch JA, Fu D, Chen J and Karlin A (1995) Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method. Neuron 14:825-831.
10. Kawauchi H, Kawazoe I, Tsubokawa M, Kishida M and Baker BI (1983) Characterization of melanin-concentrating hormone in chum salmon pituitaries. Nature (Lond) 305:321-323.
11. Kawazoe I, Kawauchi H, Hirano T and Naito N (1987) Structure-activity relationships of melanin-concentrating hormone. Int J Pept Protein Res 29:714-721.
12. Knigge KM, Baxter-Grillo D, Speciale J and Wagner J (1996) Melanotropic peptides in the mammalian brain: The melanin-concentrating hormone. Peptides 17:1063-1073.
13. Kolakowski JLK, Jung BP, Nguyen T, Johnson MP, Lynch KR, Cheng R, Heng HQ, George SR and O'Dowd BF (1996) Characterization of a human gene related to genes encoding somatostatin receptors. FEBS Lett 398:253-258.
14. Kozak M (1986) Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283-292.
15. Lebl M, Hruby VJ, Castrucci AM, Visconti MA and Hadley ME (1988) Melanin concentrating hormone analogues: Contraction of the cyclic structure. I. Agonist activity. J Med Chem 31:949-954.
16. Lembo P, Grazzini E, Cao J, Hubatach D, Pelletier M, Hoffert C, St-Onge S, Pou C, Labrecque J, Groblewski T, O'Donnell D, Payza K, Ahmad S and Walker P (1999) The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nat Cell Biol. 1:267-271.
17. Ludwig DS, Mountjoy KG, Tatro JB, Gillette JA, Frederich RC, Flier JS and Maratos-Flier E (1998) Melanin-concentrating hormone: A functional melanocortin antagonist in the hypothalamus. Am J Physiol 274:E627-E633.
18. Mansour A, Meng F, Meador-Woodruff JH, Taylor LP, Civelli O and Akil H (1992) Site-directed mutagenesis of the human dopamine D2 receptor. Eur J Pharmacol 227:205-214.
19. Maruyama K, Nagasawa H and Suzuki A (1999) 2,2′-Bispyridyl disulfide rapidly induces intramolecular disulfide bonds in peptides. Peptides 20:881-884.
20. Matsunaga TO, Castrucci AM, Hadley ME and Hruby VJ (1989) Melanin concentrating hormone (MCH): Synthesis and bioactivity studies of MCH fragment analogues. Peptides 10:349-354.
21. Naville D, Barjhoux L, Jaillard C, Faury D, Despert F, Esteva B, Durand P, Saez J and Begeot M (1996a) Mutations of ACTH receptor gene and familial syndrome of glucocorticoid deficiency. Ann Endocrinol (Paris) 57:101-106.
22. Naville D, Barjhoux L, Jaillard C, Faury D, Despert F, Esteva B, Durand P, Saez JM and Begeot M (1996b) Demonstration by transfection studies that mutations in the adrenocorticotropin receptor gene are one cause of the hereditary syndrome of glucocorticoid deficiency. J Clin Endocrinol Metab 81:1442-1448.
23. Nehring RB, Meyerhof W and Richter D (1995) Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin-14 binding. DNA Cell Biol 14:939-944.
24. Ohta K, Hayashi H, Mizuguchi H, Kagamiyama H, Fujimoto K and Fukui H (1994) Site-directed mutagenesis of the histamine H1 receptor: Roles of aspartic acid107, asparagine198 and threonine194. Biochem Biophys Res Commun 203:1096-1101.
25. Page KM, Curtis CA, Jones PG and Hulme EC (1995) The functional role of the binding site aspartate in muscarinic acetylcholine receptors, probed by site-directed mutagenesis. Eur J Pharmacol 289:429-437.
26. Paul PKC, Dauber-Osguthorpe P, Campbell MM, Brown DW, Kinsman HG, Moss C and Osguthorpe DJ (1990) Accessible conformations of melanin-concentrating hormone: A molecular dynamics approach. Biopolymers 29:623-637.
27. Prossnitz ER, Schreiber RE, Bokoch GM and Ye RD (1995) Binding of low affinity N-formyl peptide receptors to G protein. Characterization of a novel inactive receptor intermediate. J Biol Chem 270:10686-10694.
28. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek J, Kanarek R and Maratos-Flier E (1996) A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature (Lond) 380:243-247.
29. Rossi M, Choi SJ, O'Shea D, Miyoshi T, Ghatei MA and Bloom SR (1997) Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology 138:351-355.
30. Saito Y, Nothacker H-P, Wang Z, Lin SHS, Leslie F and Civelli O (1999) Molecular characterization of the melanin-concentrating hormone receptor. Nature (Lond) 400:265-269.
31. Schwarz RD, Spencer CJ, Jaen JC, Mirzadegan T, Moreland D, Tecle H and Thomas AJ (1995) Mutations of aspartate 103 in the Hm2 receptor and alterations in receptor binding properties of muscarinic agonists. Life Sci 56:923-929.
32. Schwartz TW (1994) Locating ligand-binding sites in 7TM receptors by protein engineering. Curr Opin Biotechnol 5:434-444.
33. Shimada M, Tritoa NA, Lowell BB, Flier JS and Maratos-Flier E (1998) Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature (Lond) 396:670-674.
34. Shimomura Y, Mori M, Sugo T, Ishibashi Y, Abe M, Kurokawa T, Onda H, Nishimura O, Sumino Y and Fujino M (1999) Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor. Biochem Biophys Res Commun 261:622-626.
35. Strader CD, Sigal IS, Register RB, Candelore MR, Rands E and Dixon RA (1987) Identification of residues required for ligand binding to the beta-adrenergic receptor. Proc Natl Acad Sci USA 84:4384-4388.
36. Strnad J and Hadcock JR (1995) Identification of a critical aspartate residue in transmembrane domain three necessary for the binding of somatostatin to the somatostatin receptor SSTR2. Biochem Biophys Res Commun 216:913-921.
37. Surratt CK, Johnson PS, Moriwaki A, Seidleck BK, Blaschak CJ, Wang JB and Uhl GR (1994) μ-Opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J Biol Chem 269:20548-20553.
38. Wang CD, Buck MA and Fraser CM (1991) Site-directed mutagenesis of alpha 2A-adrenergic receptors: Identification of amino acids involved in ligand binding and receptor activation by agonists. Mol Pharmacol 40:168-179.
39. Wang CD, Gallaher TK and Shih JC (1993) Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: Identification of amino acids necessary for ligand binding and receptor activation. Mol Pharmacol 43:931-940.